Stay updated on Durvalumab Combo in Advanced Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAccess to the study record now results in a 403 Forbidden page, indicating the resource is blocked. The new 403 page content includes HTML boilerplate and a simple notice, replacing the previous in-page study details.SummaryDifference17%

- Check35 days agoChange Detected2016 ( U.S. NIH Grant/Contract ) was added to the list of Other Study ID Numbers, and the page revision was updated to v3.6.6, replacing v3.6.5.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, representing a minor update to the page version. This change does not modify the study content or visible information.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded date entries: 2026-07-27, 2027-12-31, 2026-07-09, and 2026-07; removed older entries: 2026-03-20, 2026-08-27, 2026-03-19, and 2026-03 in the Study Record Dates, reflecting updated timestamp data.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision: v3.6.4 was applied to the page, signaling a minor software update. This update does not change the displayed study information.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision label on the page updated to v3.6.3, replacing v3.6.2, indicating a new version of the page content.SummaryDifference0.0%

Stay in the know with updates to Durvalumab Combo in Advanced Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.